Medical Marijuana I
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It engages in creating international CBD pipeline; produces legal cannabis products; develops cannabis drug and medication; supports services for cannabis industry; and develops market for medical cannabis. Medical Marijuana, Inc. was incorporated in 2005 and is based in Vista, Califo… Read more
Medical Marijuana I (MJNA) - Total Assets
Latest total assets as of March 2025: $67.97 Million USD
Based on the latest financial reports, Medical Marijuana I (MJNA) holds total assets worth $67.97 Million USD as of March 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Medical Marijuana I - Total Assets Trend (2009–2024)
This chart illustrates how Medical Marijuana I’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Medical Marijuana I - Asset Composition Analysis
Current Asset Composition (December 2024)
Medical Marijuana I's total assets of $67.97 Million consist of 6.3% current assets and 93.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.5% |
| Accounts Receivable | $994.07K | 1.5% |
| Inventory | $1.28 Million | 1.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $6.60 Million | 9.7% |
| Goodwill | $45.37 Million | 66.9% |
Asset Composition Trend (2009–2024)
This chart illustrates how Medical Marijuana I's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medical Marijuana I's current assets represent 6.3% of total assets in 2024, a decrease from 15.0% in 2009.
- Cash Position: Cash and equivalents constituted 1.5% of total assets in 2024, down from 10.0% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 75.0% of total assets, a decrease from 84.0% in 2009.
- Asset Diversification: The largest asset category is goodwill at 66.9% of total assets.
Medical Marijuana I Competitors by Total Assets
Key competitors of Medical Marijuana I based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Medical Marijuana I - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Medical Marijuana I generates 0.22x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Medical Marijuana I is currently not profitable relative to its asset base.
Medical Marijuana I - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.73 | 0.88 | 1.83 |
| Quick Ratio | 0.49 | 0.64 | 1.43 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.61 Million | $ -929.74K | $ 9.22 Million |
Medical Marijuana I - Advanced Valuation Insights
This section examines the relationship between Medical Marijuana I's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.59 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -2.5% |
| Total Assets | $67.83 Million |
| Market Capitalization | $1.35 Million USD |
Valuation Analysis
Below Book Valuation: The market values Medical Marijuana I's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Medical Marijuana I's assets decreased by 2.5% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Medical Marijuana I (2009–2024)
The table below shows the annual total assets of Medical Marijuana I from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $67.83 Million | -2.47% |
| 2023-12-31 | $69.55 Million | +0.92% |
| 2022-12-31 | $68.92 Million | -14.62% |
| 2021-12-31 | $80.72 Million | -4.27% |
| 2020-12-31 | $84.32 Million | -53.05% |
| 2019-12-31 | $179.61 Million | +93.21% |
| 2018-12-31 | $92.96 Million | -66.18% |
| 2017-12-31 | $274.84 Million | -30.17% |
| 2016-12-31 | $393.55 Million | +82.05% |
| 2015-12-31 | $216.18 Million | +30.16% |
| 2014-12-31 | $166.09 Million | +256.21% |
| 2013-12-31 | $46.63 Million | +184.57% |
| 2012-12-31 | $16.38 Million | +17712.75% |
| 2010-12-31 | $91.98K | -53.89% |
| 2009-12-31 | $199.49K | -- |